Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
This study has been completed.
Study NCT00919178   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on June 11, 2009.   Last Updated on December 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dengue Shock Syndrome
Dengue Hemorrhagic Fever
Additional conditions recognized in this trial
Dengue
Hemorrhagic Fevers, Viral
Shock
More general conditions related to this trial
Arbovirus Infections
Flaviviridae Infections
Flavivirus Infections
Pathologic Processes
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
DEN4 Vaccine Candidate
DEN4 Vaccine Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services